circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression

Published:2018 Issue:14 Volume:8 Page:4003-4015
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Chen Bo,Wei Weidong,Huang Xiaojia,Xie Xinhua,Kong Yanan,Dai Danian,Yang Lu,Wang Jin,Tang Hailin,Xie Xiaoming

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications;Non-coding RNA Research;2024-12

2. Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer;Pathology - Research and Practice;2024-11

3. crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer;Drug Resistance Updates;2024-11

4. The multifaceted roles of circular RNAs in cancer hallmarks: From mechanisms to clinical implications;Molecular Therapy - Nucleic Acids;2024-09

5. Circular RNAs in human diseases;MedComm;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP